SARS-CoV-2 coinfections : Could influenza and the common cold be beneficial?
© 2020 Wiley Periodicals LLC..
The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread around the world, causing serious illness and death and creating a heavy burden on the healthcare systems of many countries. Since the virus first emerged in late November 2019, its spread has coincided with peak circulation of several seasonal respiratory viruses, yet some studies have noted limited coinfections between SARS-CoV-2 and other viruses. We use a mathematical model of viral coinfection to study SARS-CoV-2 coinfections, finding that SARS-CoV-2 replication is easily suppressed by many common respiratory viruses. According to our model, this suppression is because SARS-CoV-2 has a lower growth rate (1.8/d) than the other viruses examined in this study. The suppression of SARS-CoV-2 by other pathogens could have implications for the timing and severity of a second wave.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:92 |
---|---|
Enthalten in: |
Journal of medical virology - 92(2020), 11 vom: 30. Nov., Seite 2623-2630 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pinky, Lubna [VerfasserIn] |
---|
Links: |
---|
Themen: |
Computer modeling |
---|
Anmerkungen: |
Date Completed 24.12.2020 Date Revised 16.07.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/jmv.26098 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM311364578 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM311364578 | ||
003 | DE-627 | ||
005 | 20231225142108.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/jmv.26098 |2 doi | |
028 | 5 | 2 | |a pubmed24n1037.xml |
035 | |a (DE-627)NLM311364578 | ||
035 | |a (NLM)32557776 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Pinky, Lubna |e verfasserin |4 aut | |
245 | 1 | 0 | |a SARS-CoV-2 coinfections |b Could influenza and the common cold be beneficial? |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.12.2020 | ||
500 | |a Date Revised 16.07.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2020 Wiley Periodicals LLC. | ||
520 | |a The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread around the world, causing serious illness and death and creating a heavy burden on the healthcare systems of many countries. Since the virus first emerged in late November 2019, its spread has coincided with peak circulation of several seasonal respiratory viruses, yet some studies have noted limited coinfections between SARS-CoV-2 and other viruses. We use a mathematical model of viral coinfection to study SARS-CoV-2 coinfections, finding that SARS-CoV-2 replication is easily suppressed by many common respiratory viruses. According to our model, this suppression is because SARS-CoV-2 has a lower growth rate (1.8/d) than the other viruses examined in this study. The suppression of SARS-CoV-2 by other pathogens could have implications for the timing and severity of a second wave | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a SARS coronavirus | |
650 | 4 | |a computer modeling | |
650 | 4 | |a human metapneumovirus | |
650 | 4 | |a human rhinovirus | |
650 | 4 | |a influenza virus | |
650 | 4 | |a respiratory syncytial virus | |
700 | 1 | |a Dobrovolny, Hana M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of medical virology |d 1990 |g 92(2020), 11 vom: 30. Nov., Seite 2623-2630 |w (DE-627)NLM000285676 |x 1096-9071 |7 nnns |
773 | 1 | 8 | |g volume:92 |g year:2020 |g number:11 |g day:30 |g month:11 |g pages:2623-2630 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/jmv.26098 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 92 |j 2020 |e 11 |b 30 |c 11 |h 2623-2630 |